Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

nohla therapeutics receives fda orphan drug designation for dilanubicel for hematopoietic stem cell transplant patients
Read Me

nohla therapeutics announces second closing of $56 million series b financing
Read Me

rare endocrine disease biotech crinetics pharmaceuticals sets terms for $80 million ipo
Read Me

nodthera secures £28 million ($40 million) series a financing
Read Me

zemdri (plazomicin) approved by fda for the treatment of adults with complicated urinary tract infections (cuti)

Pushing the healthcare industry forward

$ 1 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $285M from our fifth fund.
65

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
30

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 2000 patients enrolled across 250 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA